PSA Level Greater Than or Equal to Two: Clinical Trials

2 trials for PSA Level Greater Than or Equal to Two, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated, 1 withdrawn. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 1, Withdrawn 1
Phase 11Withdrawn 1

Follow PSA Level Greater Than or Equal to Two: new trials by email Literature Review of PSA Level Greater Than or Equal to Two trials Research Report on PSA Level Greater Than or Equal to Two

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer
Decitabine, Enzalutamide - Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma
Phase 1 / Phase 2WithdrawnRoswell Park Cancer Institute2021-04-152022-10-05
Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency
Carboplatin, Docetaxel, Laboratory Biomarker Analysis - ATM Gene Mutation, BRCA1 Gene Mutation
Phase 2TerminatedUniversity of Washington182018-08-242026-08-26

Narrower conditions

Prostatic Neoplasms (1)

Broader conditions

Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Genital Neoplasms, Male (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Prostatic Diseases (1)  ·  Urogenital Diseases (1)  ·  Urogenital Neoplasms (1)

Interventions

Carboplatin (1)  ·  Decitabine (1)  ·  Docetaxel (1)  ·  Injections (1)  ·  enzalutamide (1)  ·  rucaparib (1)

Sponsors

Roswell Park Cancer Institute (1)  ·  University of Washington (1)

Countries

United States (2)

Top investigators

Gurkamal Chatta (1)  ·  Heather H. Cheng (1)